Click Here for 5% Off Your First Aladdin Purchase!

JBJ-09-063 hydrochloride - ≥98%, high purity , CAS No.2820336-67-0(free base), Allosteric modulator of epidermal growth factor receptor

  • Moligand™
  • ≥98%
Item Number
J611228
Grouped product items
SKUSizeAvailabilityPrice Qty
J611228-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$270.90
J611228-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$940.90

Basic Description

Specifications & Purity≥98%
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeALLOSTERIC MODULATOR
Mechanism of actionAllosteric modulator of epidermal growth factor receptor
Product Description

JBJ-09-063 hydrochloride is a mutant-selective allosteric EGFR inhibitor with IC50s of 0.147 nM, 0.063 nM, 0.083 nM and 0.396 nM for EGFR L858R, EGFR L858R/T790M, EGFR L858R/T790M/C797S and EGFRLT/L747S. JBJ-09-063 hydrochloride effectively reduces EGFR, Akt and ERK1/2 phosphorylation. JBJ-09-063 hydrochloride is effective across EGFR tyrosine kinase inhibitor (TKI)-sensitive and resistant models. JBJ-09-063 hydrochloride can be used for researching EGFR-mutant lung cancer.

Associated Targets

EGFR Tclin Epidermal growth factor receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Molecular Weight 556.65(free base)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SensitivityMoisture sensitive

Related Documents

References

1. To C, Beyett TS, Jang J, Feng WW, Bahcall M, Haikala HM, Shin BH, Heppner DE, Rana JK, Leeper BA et al..  (2022)  An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer..  Nat Cancer,  (4): (402-417).  [PMID:35422503]

Solution Calculators